Unmasking Panic Disorder in Adults with Leukemia: A Systematic Review of Prevalence, Risk Factors, and Management
Psychopharmacology Bulletin · 2026-10-29 · 56 (4) · 112-120
DOI: 10.64719/pb.21618 ↗Abstract
Objective To assess prevalence, risk factors, and management of panic disorder in adult leukemia patients. Methods A PRISMA-guided systematic search of PubMed, Embase, PsycINFO, and Cochrane Library (2015–July 20, 2025) identified studies on adults (⩾18 years) with leukemia and panic disorder or anxiety, diagnosed via DSM/ICD or validated scales (e.g., HADS-A). Data on prevalence, risk factors, and treatments were extracted. Quality was assessed using the Newcastle-Ottawa Scale. Results Seven studies (n = 1,292) reported anxiety prevalence of 15%–39% and panic disorder at 2%–8%. Risk factors included younger age and chemotherapy. CBT and SSRIs were effective. Conclusions Panic disorder affects leukemia patients’ quality of life, necessitating routine screening.
EUVIMED